ORamaVR

Company profile

ORamaVR company profile

ORamaVR aims to accelerate world’s transition to medical VR training by democratizing the VR metaverse content creation and offering an IT platform (MAGES-SDK) to medical organizations, enabling the mass production of high fidelity medical Virtual Reality Simulations at 1/8th of cost and time against current practices. These medical VR training simulations are then being used by hospitals, medical device companies, medical schools and medical training centres to train as well as assess their medical professionals. The outstanding benefits of this award-winning platform (MAGES SDK) have been demonstrated in 9 published clinical trials and over 50 scientific publications by the team scientists. Numerous high profile institutions have already adopted and endorsed ORamaVR, including (but not limited to) the USC Keck School of Medicine, Los Angeles, NYU Langone Medical School in New York, the University of Geneva, the Swiss Foundation for Innovation and Training in Surgery(SFITS), Virtamed™  SA and the Inselspital Hospital system in Switzerland, the University of Athens, Greece and recently Western Governors University, Fayetteville State University, Atrium Health and the University of Michigan in USA as well as the University of Cologne, and nonNocere SA in Germany. ORamaVR has won several prestigious international awards, including the “best societal impact” award by the Latsis Foundation (2021), the Epic Games Mega-Grant (2020), the Augmented World Expo (AWE) Auggie award for “Best Societal Impact” (2019) and the prestigious FARE award by the American Association of Hip and Knee Surgeons (AAHKS) (2018). ORamaVR has also attracted substantial deep-tech R&D projects and boasts important research and industrial partnerships, including Airbus, Telefonica, CNRS, Microsoft and Eurescom. ORamaVR has attracted venture capital funding from important angel, institutional as well as strategic investors, such as HTC Vive, a leader in enterprise virtual reality worldwide.